Hayato Maruoka - Concepedia

Author

Hayato Maruoka

Kobe City Medical Center General Hospital

Also Known As

H Maruoka, Hayato Maruoka, Y Ohyama

Publications

485

Citations

H-Index

Concepts

All Affiliations

Kobe City Medical Center General Hospital The University of Osaka Kuma Hospital Shinko Hospital The University of Tokyo

About

Hayato Maruoka is an author at Kobe City Medical Center General Hospital specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	201
2	Cell Biology	4	4	72
3	Health Sciences	1	1	25
4	Allergy	1	1	13
5	Gastroenterology	1	1	13

Hayato Maruoka

Publications

334

Citations

H-Index

Page 1

	Year	Citations
Independent Involvement of CD8 <sup>+</sup> CD25 <sup>+</sup> Cells and Thyroid Autoantibodies in Disease Severity of Hashimoto's Disease Mikio Watanabe, Naoko Yamamoto, Hayato Maruoka, Thyroid	2002	53
IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome Hayato Maruoka, Daichi Inoue, Yoko Takiuchi, Annals of Hematology Hematological MalignancyLymphoid NeoplasiaAutoimmune DiseaseImmunodeficienciesMalignant Blood Disorder	2013	52
Successful Treatment of POEMS Syndrome Complicated by Severe Congestive Heart Failure with Thalidomide Daichi Inoue, Aiko Kato, Sumie Tabata, Internal Medicine Translational MedicineHeart FailurePoems Syndrome ComplicatedPoems SyndromeCardiovascular Disease	2010	37
Impact of folate therapy on combined immunodeficiency secondary to hereditary folate malabsorption Kenji Kishimoto, Ryōji Kobayashi, Hirozumi Sano, Clinical Immunology Combined ImmunodeficiencyHereditary Folate MalabsorptionFolate Therapy	2014	26
Leukemic Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm Lacking Skin Lesion : A Borderline Case between Acute Monocytic Leukemia Yoko Takiuchi, Hayato Maruoka, Kazunari Aoki, Journal of Clinical and Experimental Hematopathology Mixed-phenotype Acute LeukemiaImmunologyPathologyTumor CellsDermatology	2012	25
Expression of multiple leukemic stem cell markers is associated with poor prognosis in <i>de novo</i> acute myeloid leukemia Tomohiro Yabushita, Hironaga Satake, Hayato Maruoka, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyTumor BiologyMedicineAcute Myeloid LeukemiaStem Cells	2017	25
Involvement of genes encoding apoptosis regulatory factors ( FAS, FASL , TRAIL , BCL2 , TNFR1 and TNFR2 ) in the pathogenesis of autoimmune thyroid diseases Naoya Inoue, Mikio Watanabe, Naoko Ishido, Human Immunology Signal TransductionAutoimmune DiseaseAutoantibody ProductionApoptosis Regulatory FactorsMedicine	2016	20
Impact of occult bone marrow involvement on the outcome of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone therapy for diffuse large B-cell lymphoma Hiroshi Arima, Hayato Maruoka, K Nasu, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyPretreatment CharacteristicsLymphoid NeoplasiaBone Marrow FailureMedicine	2013	15
Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study Takatsugu Ogata, Hironaga Satake, Misato Ogata, Oncotarget	2019	15
CD38 expression is an important prognostic marker in diffuse large B‐cell lymphoma Fumiya Wada, Yoshimitsu Shimomura, Tomohiro Yabushita, Hematological Oncology	2021	15

Page 1